Northern Trust’s GT Biopharma GTBP Stock Holding History

Northern Trust’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37K	Buy	+75,461	New	+$30.6K	﹤0.01%	4312
2024 Q1	–	Sell	-1,078	Closed	-$8.25K	–	4447
2023 Q4	$8.25K	Hold	1,078	–	–	﹤0.01%	4430
2023 Q3	$7.8K	Hold	1,078	–	–	﹤0.01%	4413
2023 Q2	$10.1K	Hold	1,078	–	–	﹤0.01%	4477
2023 Q1	$17.8K	Sell	1,078 -21	-2%	-$481	﹤0.01%	4469
2022 Q4	$29.2K	Hold	1,099	–	–	﹤0.01%	4402
2022 Q3	$58K	Sell	1,099 -211	-16%	-$16.1K	﹤0.01%	4286
2022 Q2	$118K	Sell	1,310 -4,150	-76%	-$315K	﹤0.01%	4104
2022 Q1	$472K	Sell	5,460 -222	-4%	-$19.6K	﹤0.01%	3762
2021 Q4	$520K	Buy	5,682 +112	+2%	+$16.8K	﹤0.01%	3793
2021 Q3	$1.13M	Sell	5,570 -1,945	-26%	-$585K	﹤0.01%	3513
2021 Q2	$3.5M	Buy	7,515 +6,369	+556%	+$2.65M	﹤0.01%	3052
2021 Q1	$235K	Buy	+1,146	New	+$200K	﹤0.01%	4056

Other funds holding GTBP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return

4WM

49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return

Alongside Austin, Texas $525M AUM

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Northern Trust's GTBP Position: Q2 2026 in Review

Northern Trust opened a new position in GT Biopharma (GTBP) in Q2 2026: 75,461 shares worth $37K. The stake represents ﹤0.01% of the portfolio and ranks #4312 among its holdings. This is a return to the name: Northern Trust previously reported a position in GTBP as recently as Q4 2023.

Northern Trust first reported a position in GTBP in Q1 2021 and has held it in 13 quarters since. The position peaked at $3.5M in Q2 2021. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

Northern Trust held 75,461 shares of GT Biopharma worth $37K as of Q2 2026.
GT Biopharma was a new Northern Trust position in Q2 2026.
GT Biopharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4312 holding.
Northern Trust first reported a position in GT Biopharma in Q1 2021 and has held it in 13 quarters since.
Northern Trust's GT Biopharma position peaked at $3.5M in Q2 2021.
59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.